<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><id>http://publicationslist.org/data/susanne.gahr/atom.xml</id><title>Susanne Gahr's Publications List</title>
<link rel="self" type="application/atom+xml" href="http://publicationslist.org/data/susanne.gahr/atom.xml"/><link rel="alternate" type="text/html" href="http://publicationslist.org/susanne.gahr"/><author><name>Susanne Gahr</name><uri>http://publicationslist.org/susanne.gahr</uri></author><icon>$basepathfavicon.ico</icon><subtitle>Recent additions to Susanne Gahr's PublicationsList.org page</subtitle><logo>http://publicationslist.org/publications.png</logo><updated>2008-07-08T06:10:08Z</updated>

<entry>
<id>http://publicationslist.org/susanne.gahr/refid1</id>
<updated>2008-07-08T06:10:04Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/susanne.gahr#refid1'/>
<title type='html'>The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells.</title>
<summary type='html'>The prognosis of advanced pancreatic cancer is poor. Established chemotherapy shows only limited efficacy and significant side effects. We investigated how far a combination of trichostatin A (TSA) and gemcitabine synergizes to inhibit proliferation and promotion of apoptosis of pancreatic adenocarcinoma cells in vitro. The human pancreatic carcinoma cells YAPC, DANG and Panc-89 and primary human ...&lt;br/&gt;&lt;br/&gt;Susanne Gahr, Matthias Ocker, Marion Ganslmayer, Steffen Zopf, Kinya Okamoto, Andrea Hartl, Sandra Leitner, Eckhart G Hahn, Christoph Herold (2007)  &lt;i&gt;Int J Oncol&lt;/i&gt; 31: 3 567-576&lt;br/&gt;</summary>
</entry>
</feed>
